Quantbot Technologies LP bought a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI – Free Report) during the second quarter, Holdings Channel reports. The fund bought 54,267 shares of the company’s stock, valued at approximately $1,255,000.
Several other large investors have also recently bought and sold shares of the company. Global Retirement Partners LLC purchased a new position in shares of Bath & Body Works during the 4th quarter valued at $31,000. Activest Wealth Management purchased a new stake in shares of Bath & Body Works in the fourth quarter worth $32,000. Geneos Wealth Management Inc. raised its position in shares of Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after buying an additional 801 shares in the last quarter. Parallel Advisors LLC boosted its stake in Bath & Body Works by 42.6% during the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock valued at $38,000 after buying an additional 567 shares during the period. Finally, Danske Bank A S bought a new stake in Bath & Body Works during the third quarter valued at $39,000. 95.14% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of equities analysts have weighed in on the company. Raymond James Financial restated a “market perform” rating on shares of Bath & Body Works in a research note on Wednesday, May 27th. Citigroup upgraded Bath & Body Works from a “neutral” rating to a “buy” rating and set a $25.00 price target for the company in a research report on Tuesday, August 18th. JPMorgan Chase & Co. boosted their price objective on Bath & Body Works from $22.00 to $24.00 and gave the stock a “neutral” rating in a report on Tuesday, August 18th. Barclays decreased their price objective on shares of Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating on the stock in a research report on Thursday, May 28th. Finally, UBS Group reaffirmed a “neutral” rating on shares of Bath & Body Works in a research note on Wednesday, August 19th. Four research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $22.57.
Bath & Body Works Stock Performance
BBWI stock opened at $17.58 on Wednesday. The firm has a market cap of $3.54 billion, a P/E ratio of 4.94, a P/E/G ratio of 1.89 and a beta of 1.38. The firm’s fifty day moving average is $20.39 and its 200 day moving average is $20.03. Bath & Body Works, Inc. has a 52 week low of $14.27 and a 52 week high of $32.32.
Bath & Body Works (NYSE:BBWI – Get Free Report) last posted its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.03. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The business had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.36 billion. During the same period in the previous year, the firm posted $0.49 earnings per share. The firm’s revenue for the quarter was down 3.2% on a year-over-year basis. As a group, analysts forecast that Bath & Body Works, Inc. will post 2.63 EPS for the current year.
Bath & Body Works Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 4th. Stockholders of record on Friday, August 21st will be issued a $0.20 dividend. The ex-dividend date is Friday, August 21st. This represents a $0.80 annualized dividend and a dividend yield of 4.6%. Bath & Body Works’s payout ratio is currently 22.47%.
Bath & Body Works Company Profile
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
See Also
- Five stocks we like better than Bath & Body Works
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
